Profiel
Ludovic Robin served as Deputy Chief Executive Officer at Advicenne SA. He worked at Shire Plc as Marketing Director & Head-Commercial Operations from 2008 to 2016.
Robin also served as Chief Business Officer at PCI Biotech Holding ASA from 2020 to 2022.
He holds an MBA from École des Hautes Études Commerciales de Paris, a doctorate from the University of Lyon, and a graduate degree from Institut de Pharmacie Industrielle de Lyon.
Eerdere bekende functies van Ludovic Robin
Bedrijven | Functie | Einde |
---|---|---|
PCI BIOTECH HOLDING ASA | Corporate Officer/Principal | 01-05-2022 |
SHIRE | Corporate Officer/Principal | - |
ADVICENNE | Corporate Officer/Principal | - |
Opleiding van Ludovic Robin
École des Hautes Études Commerciales de Paris | Masters Business Admin |
University of Lyon | Doctorate Degree |
Institut de Pharmacie Industrielle de Lyon | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PCI BIOTECH HOLDING ASA | Health Technology |
ADVICENNE | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |